Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,000
Closed -$1.05M 1175
2025
Q4
$1.05M Hold
10,000
0.01% 400
2025
Q3
$839K Hold
10,000
0.01% 386
2025
Q2
$792K Buy
+10,000
New +$795K 0.01% 315

Other funds holding MRK

Marex Group's MRK Position: Q1 2026 in Review

Marex Group increased its Merck (MRK) stake by 118% in Q1 2026, buying an estimated $681K and bringing the position to 10,904 shares worth $1.31M. The position accounts for 0.01% of the portfolio, ranked #386.

Marex Group first reported a position in MRK in Q4 2022 and has held it in 13 quarters since. The position peaked at $13.7M in Q4 2023. 3,776 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Marex Group held 10,904 shares of Merck worth $1.31M as of Q1 2026.
  • Marex Group bought 5,896 Merck shares in Q1 2026, an estimated $681K.
  • Merck made up 0.01% of Marex Group's portfolio in Q1 2026, its #386 holding.
  • Marex Group first reported a position in Merck in Q4 2022 and has held it in 13 quarters since.
  • Marex Group's Merck position peaked at $13.7M in Q4 2023.
  • 3,776 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.